Abstract 4822: Targeting RAS and downstream signaling in high-grade serous ovarian carcinoma with novel RAS inhibitors

Authors: Tyler E. Mattox, Tiffany S. Norton, Adam B. Keeton, Antonio B. Ward, Yulia Y. Maxuitenko, Kristy L. Berry, Bing Zhu, Alla Musiyenko, Elaine Gavin, Veronica Ramirez-Alcantara, Xi Chen, Jacob Valiyaveettil, Jennifer Scalici, Rodney P. Rocconi, Gary A. Piazza, Luciana Madeira da Silva

Published: 2019-08-07

DOI: 10.1158/1538-7445.am2019-4822

Source: Full article